EPTIS
BAM Logo

BNP Programme

EPTIS factsheet 142554 | Last revision 2023-04-25 | URL: https://www.eptis.bam.de/pts142554 https://www.eptis.bam.de/pts142554

PT provider
PT provider WEQAS Quality Laboratory WEQAS Quality Laboratory
Based in United Kingdom
Language(s)
Remarks EQA BNP 32 scheme, recombinant Human BNP 32 is added to EDTA plasma and for NT-pro BNP, recombinant Human NT-pro BNP is added to lithium heparin plasma. Three liquid human plasma samples are distributed bimonthly.
Keywords
Product groups Health care / medical devices
Human test material
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
Human EDTA plasma Brain Natriuretic Peptide (BNP) -
NT-proBNP -
POCT BNP -
Aims of the PT scheme
Target group of participants Laboratory Diagnostic Services
Linked to specific legislation / standards Accreditation by UKAS on the basis of ISO/IEC 17025, 17043 and 15195
Additional, subsidiary aims validation of testing methods
Number of participants
Accredited or otherwise reviewed by a 3rd party

Accredited by UKAS on the basis of ISO/IEC 17043

Operation is commissioned / requested by
Fees and frequency
Participation fee Fee dependent on number of participating sections and proximetry of testing methods.
Regularly operated Yes (Bi-monthly, 3 sets of samples )
Year of first operation 2007
Contact details of the PT provider
Provider Contact person
WEQAS Quality Laboratory
Unit 6, Parc Ty Glas
CF14 5DU Cardiff
United Kingdom

Phone: 44 (0) 2920 747810
Fax: 44 (0) 2920 314760
Web: http://www.weqas.com http://www.weqas.com
Laura Lloyd-Lewis
Phone: 44 (0) 29218 41287
Fax:
Email: laura.lloyd-lewis@wales.nhs.uk laura.lloyd-lewis@wales.nhs.uk
If you find any mistakes please contact the responsible EPTIS coordinator in United Kingdom, Mr Savvas Xystouris. Mr Savvas Xystouris.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5